Concepedia

Adrien Herlédan

AH

19

Publications

754

Citations

15

H-Index

2006

Active since

Affiliations

Inserm(Current)

Université de Lille

Institut Pasteur de Lille

Médicaments et Molécules pour Agir sur les Systèmes Vivants

Centre National de la Recherche Scientifique

Adrien Herlédan is an author at Inserm specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2006–2023

19

Publications

19

Receptor-Interacting Protein 140 Differentially Regulates Estrogen Receptor-Related Receptor Transactivation Depending on Target Genes

Audrey Castet, Adrien Herlédan, Sandrine Bonnet et al. · Molecular Endocrinology · 2006 · 106 citations · Full text

, , +18

Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Rebecca Deprez‐Poulain, Nathalie Hennuyer, Damien Bosc et al. · Nature Communications · 2015 · 93 citations · Full text

Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis

Marc Bitoun, Anne‐Cécile Durieux, Bernard Prudhon et al. · Human Mutation · 2009 · 81 citations · Full text

BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation

Maxime Sartori, Tiago Mendes, Shruti Desai et al. · Acta Neuropathologica · 2019 · 64 citations · Full text

, , +18

Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps

Coline Plé, Heng-Keat Tam, Anaïs Vieira Da Cruz et al. · Nature Communications · 2022 · 61 citations · Full text

Rows per page

1–5 of 19